🇺🇸 FDA
Patent

US 10960070

Prefusion coronavirus spike proteins and their use

granted A61KA61K39/12A61K39/215

Quick answer

US patent 10960070 (Prefusion coronavirus spike proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K39/12, A61K39/215, A61P, A61P31/14